""

Urothelial carcinoma of the urinary bladder (incl. renal pelvis, ureter)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

Title: An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreated locally advanced or metastatic urothelial cancer
Phase: III
Contact: Stephanie Cordeiro de Lima / Study Nurse
Clinical Investigator: Dr. Stefanie Zschäbitz
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04223856
EudraCT-Number: (siehe EU klinisches Studienregister) 2019-004542-15

Metastatic Disease: Follow-Up Treatment

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available